/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present.
/PRNewswire/ The "Global Prosthetic Heart Valve Market Size, Share & Industry Trends Analysis Report By End User (Hospitals & Cardiac Centers and Ambulatory.
/PRNewswire/ The "Global Prosthetic Heart Valve Market Size, Share & Industry Trends Analysis Report By End User (Hospitals & Cardiac Centers and Ambulatory.
Artivion, Inc. (NYSE:NYSE:AORT) Q2 2022 Earnings Conference Call August 04, 2022, 16:30 ET Company Participants Brian Johnston - Gilmartin Group James Mackin - Chairman, President & CEO.
KENNESAW, Ga. (AP) Artivion, Inc. (AORT) on Thursday reported a loss of $4.3 million in its second quarter. The Kennesaw, Georgia-based company said it had a loss of 11 cents per share. Losses, adjusted for one-time gains and costs, were 3 cents per share.